	Recurrence detection in patients with triple-negative breast cancer following the current standard of care: a microsimulation model. BMJ Open Samur S, Hoban O, Gu NY, Carter GC, Palomares M, Arrick B, Gursel E, Yildiz Y, Ayer T, Chhatwal J, Parsons HA. PMID: 42749377 [PubMed - indexed for MEDLINE]
	Occult breast carcinoma presenting as paraneoplastic opsoclonus-myoclonus-ataxia syndrome. BMJ Case Rep Hassan SA, Bezbaruah A, Payeng D, Ahmed A. PMID: 42749342 [PubMed - indexed for MEDLINE]
	Neural Remodeling Shapes a Nerve-Dependent Metastatic Ecosystem in Ovarian Cancer. Pharmacol Res Ou L, Feng C, Sun C, Xue Z, Liu D, Gong Q, An Y, Luo Y, Sheng P, Wang Z, Li ZH, Gao CZ, Yin H, Ma N, Xu KF, Wu FG, Shen Y. PMID: 42749097 [PubMed - as supplied by publisher]
	Left Atrial Strain as an Early Marker of Anthracycline-Related Cardiac Dysfunction (LAS-MACD). Echocardiography Tanking C, Samansit N, Wuttichaipradit C. PMID: 42748960 [PubMed - indexed for MEDLINE]
	Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trials. Cancer Treat Rev Dud, Zeghondy J, Emile G, Simon C, Lottin M, Marra A, Aftimos P, Boussios S, Xu-Vuillard A, Lion O, Serhal C, Ribeiro JM, Pistilli B, Michiels S, Rassy E. PMID: 42748873 [PubMed - as supplied by publisher]
	Transcriptomic signatures of mind-body transformations therapy in breast cancer: Downregulation of the interferon signaling pathway. Breast Cocco S, Cozzolino M, Piezzo M, Celia G, Barberio D, Abate V, Calabrese A, Von Arx C, Di Rienzo R, Costantini S, Budillon A, De Laurentiis M. PMID: 42748847 [PubMed - as supplied by publisher]
	Comparative oncological efficacy of chemotherapy, cytoreductive surgery with or without HIPEC in recurrent ovarian cancer: A network meta-analysis. Eur J Surg Oncol Sassun R, Kusamura S, Baratti DCA, Guaglio M, Colletti G, Nava FL, Brucchi F, Sileo A, Brescacin A, Bhatt A, Cavalleri T, Deraco M. PMID: 42748584 [PubMed - as supplied by publisher]
	Accuracy and Safety of Large Language Models in Endometrial Cancer Decision Making: A Case-Based In Silico Benchmarking Study. JCO Clin Cancer Inform Perrone E, Parisi G, Giuliano MC, Capasso I, Macellari N, Russo L, Santoro A, Fanfani F. PMID: 42748382 [PubMed - indexed for MEDLINE]
	Validation of Ukrainian breast and cervical cancer screening questionnaire. Wiad Lek Ponzel N, Kolesnik P. PMID: 42748308 [PubMed - indexed for MEDLINE]
	Correlation of serum tumor markers (CEA and CA15-3) with clinicopathological features in breast cancer patients in Iraq. Wiad Lek Kermasha ZW, Al-Joubouri ZT, Behlul R, Alkabi YSA, Mohammed AJ. PMID: 42748301 [PubMed - indexed for MEDLINE]
	Comparative evaluation of ChatGPT and gemini responses to patient-oriented questions on breast cancer. PLoS One Yilmaz Bozok Y, Acar N, Atahan MK, Karaali C. PMID: 42748159 [PubMed - indexed for MEDLINE]
	Characterizing the Objective Time Spent on Health Care Activities in Clinic and at Home for Patients With Cancer. Cancer Med Rocque GB, Henderson NL, Parsons HM, Brown K, Huang Z, Gupta A, Teoh D, Fan Y, Blaes A, Odom JN, Arend R, Wolfson J, Vogel RI. PMID: 42747975 [PubMed - indexed for MEDLINE]
	Association between cumulative symptom burden and cognitive impairment among breast cancer survivors: a cross-sectional study. Breast Cancer Res Treat Li X, Lampson K, Liou KT, Li Y, Li SQ, Ahles T, Root J, Mao JJ. PMID: 42747658 [PubMed - indexed for MEDLINE]
	Metastatic phenotype and post-metastatic survival across HER2-0, HER2-low, and HER2-positive breast cancer. Breast Cancer Res Treat Sanjari Moghaddam A, Deng Z, Sereika SM, Habib M, Homeniuk A, Brufsky AM, Rosenzweig MQ. PMID: 42747633 [PubMed - indexed for MEDLINE]
	Identification of a circulating miR-6838-5p/miR-195-5p signature in invasive ductal breast carcinoma. Mol Biol Rep Zeytunlu MB, Duzdag FEI, Esin H, Aktan C, Kaymaz BT. PMID: 42747628 [PubMed - indexed for MEDLINE]
	Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer - results from the phase II DETECT IVb trial. Breast Cancer Res Treat Schochter F, Friedl TWP, Schäffler H, Meier-Stiegen F, Pfister KN, Riethdorf S, Wiesmüller L, Neubauer H, Müller L, Wimberger P, Fasching PA, Lorenz R, Hempel T, Heublein S, Hartkopf A, Pantel K, Rack B, Müller V, Fehm T, Janni W, Cieslik JP. PMID: 42747616 [PubMed - indexed for MEDLINE]
	Trends in contralateral prophylactic mastectomy and genetic testing in the era of new society guidelines. Breast Cancer Res Treat Reagan AM, Rutherford CR, Prathibha S, Levy BE, Praska C, Thacker SE, Kolbow M, Ozed-Williams B, Karnik KN, Mangino AA, Marmor S, Tuttle TM, Hui JYC, Burke EE. PMID: 42747564 [PubMed - indexed for MEDLINE]
	Contemporary therapy for small node-negative triple-negative breast cancer: a retrospective cohort study. Breast Cancer Res Treat Lee B, Santos B, McArthur H, LeVee A, Kordic A, Zhang S, J Gruber J. PMID: 42747549 [PubMed - indexed for MEDLINE]
	Effectiveness of an eHealth intervention to improve quality of life in long-term breast cancer survivors: a 9-month randomized controlled trial. J Natl Cancer Inst Pimentel-Parra GA, Escalada-Hernández P, San Martín-Rodríguez L, García-Vivar C, Soto-Ruiz N. PMID: 42747290 [PubMed - as supplied by publisher]
	Ovarian Cancer Lymphocele Risk: A Delphi-Based Retrospective Model Development and Validation. Cancer Control Lu L, Zhang T, Zhu Y, Zhao L, Xu J, Zhang Q, Li C, Wu X, Cheng X. PMID: 42747025 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335245

Page 1 of 16763



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy